Ceftriaxone

Drug Class & Mechanism

Spectrum of Activity

Pharmacokinetics

Clinical Indications & Dosing

Gonorrhea dosing note: CDC STI Guidelines (p. 75) recommend 500 mg IM single dose (up from 250 mg) due to rising MICs among circulating N. gonorrhoeae isolates. A 500 mg dose maintains drug concentrations above MIC 0.03 µg/mL for ~50 hours.

Adverse Effects

Key Drug Interactions

• Calcium-containing IV fluids (e.g., Ringer's lactate): contraindicated concurrently in neonates; avoid Y-site co-administration in all patients
• Warfarin: may potentiate anticoagulant effect
• Aminoglycosides: physical incompatibility — do not mix in same IV line

Special Populations

Summary

Vitamin A in Measles

Dosing by Age

Third "Deficiency" Dose

Key Points

• Vitamin A markedly reduces morbidity and mortality in measles, even in non-deficient children.
• Although vitamin A deficiency is not widely recognized in high-income countries, studies show many American children with measles have low serum vitamin A levels and experience increased complications.
• The AAP recommends considering two consecutive daily doses for all children hospitalized with measles or its complications.
• Route: oral (if the child cannot take oral medication, IM preparations may be used).
• Mechanism of benefit: measles depletes vitamin A stores, impairs epithelial integrity and immune function — supplementation reverses this.

Measles (Rubeola)

Etiology & Epidemiology

• Causative agent: Measles virus — single-stranded RNA virus, family Paramyxoviridae, genus Morbillivirus
• Transmission: Respiratory droplets and airborne; one of the most contagious pathogens known (R₀ ~12–18)
• Outbreaks can occur when <10% of a population is susceptible
• No latent or persistent reservoir — humans are the only host
• Common transmission settings: households, schools, healthcare facilities

Pathogenesis

• Virus enters via respiratory epithelium → infects local lymphoid tissue → primary viremia → dissemination to reticuloendothelial system → secondary viremia → skin, respiratory tract, and other organs
• Causes profound transient immunosuppression (lymphopenia, impaired T-cell responses) — increases susceptibility to secondary bacterial infections
• Depletes vitamin A stores, impairing epithelial integrity and immunity

Clinical Features

Prodrome (Days 1–4)

• High fever (can exceed 40°C)
• The 3 C's: Cough, Coryza, Conjunctivitis
• Koplik's spots (pathognomonic): tiny white/blue-gray spots on bright red buccal mucosa, opposite lower molars — appear 1–2 days before rash

Exanthem (Day 3–5 of illness)

• Maculopapular rash begins at the hairline/behind ears → spreads downward (face → trunk → extremities) over 3 days
• Rash lasts 5–6 days, fades in order of appearance
• Fever typically peaks with rash onset then defervesces

CDC Case Definition (Harrison's, p. 6035)

1. Generalized maculopapular rash ≥ 3 days
2. Fever ≥ 38.3°C (101°F)
3. Cough, coryza, or conjunctivitis

Diagnosis

Clinical diagnosis is harder in: early prodrome, immunocompromised patients, attenuated disease from prior vaccination/passive antibodies, or low-incidence settings.

Complications

Common

Serious / Neurologic

In Special Populations

• Malnourished/vitamin A–deficient children: severe disease, high mortality, corneal ulceration → blindness
• Immunocompromised: atypical rash, giant cell pneumonia, no Koplik's spots
• Pregnancy: spontaneous abortion, premature labor, maternal mortality

Treatment

Prevention

Key Numbers to Remember

Hydrocortisone in Pediatrics — Age Limit

Topical Hydrocortisone

• Hydrocortisone 1% (OTC): Generally considered safe from 2 years of age and above for short-term use
• Below 2 years: Use only under physician supervision — infants have a higher surface area-to-body weight ratio, increasing systemic absorption risk
• Below 3 months: Generally avoided unless specifically indicated by a specialist (risk of adrenal suppression, skin atrophy)
• Face, flexures, groin: Use with extra caution at any age due to thin skin and enhanced absorption

Key Risks in Infants

As an alternative, topical calcineurin inhibitors (tacrolimus 0.03%, pimecrolimus 1%) are approved as second-line therapy for atopic dermatitis in children ≥2 years, with no risk of atrophy or adrenal suppression (Atopic Dermatitis Guidelines, p. 7).

Systemic Hydrocortisone (IV/IM/Oral)

• No absolute lower age limit — can be used in neonates and preterm infants for specific indications (adrenal insufficiency, congenital adrenal hyperplasia, refractory septic shock)
• Doses are weight-based and indication-specific:

Natal Teeth

Definition

Incidence

• Approximately 1 in 2,000–3,500 births
• Most commonly affect the mandibular central incisors (~85% of cases)

Classification (Massler & Savara)

Etiology & Associations

• Most are isolated findings (idiopathic)
• Associated conditions:
  • Ellis-van Creveld syndrome
  • Hallermann-Streiff syndrome
  • Pierre Robin sequence
  • Sotos syndrome
  • Pachyonychia congenita

Clinical Concerns

Management

Key point: The decision to extract vs. retain depends on the degree of mobility. A firm natal tooth that is part of the normal primary dentition should be preserved whenever possible to avoid space loss.

The Golden Minute in Neonatal Resuscitation

Definition

The Initial Steps (To Be Completed Within 60 Seconds)

At Birth — Rapid Assessment (First ~5 seconds)

1. Term gestation?
2. Good tone?
3. Breathing or crying?

If all 3 YES → routine care (keep warm, dry, stimulate, monitor) If any NO → proceed with resuscitation steps

Steps During the Golden Minute

Meconium-stained fluid note: Routine intrapartum suctioning is no longer recommended. Intubation and suctioning are done only if the infant is non-vigorous (poor tone, apnea, HR <100).

Decision Point at 60 Seconds

Positive Pressure Ventilation (PPV) — If Needed

• Rate: 40–60 breaths/minute
• Pressure: 20–25 cmH₂O initial (up to 30–40 for term infants if needed)
• FiO₂:
  • Term infants: start with 21% O₂ (room air)
  • Preterm (<35 weeks): start with 21–30% O₂
• Reassess HR after 15 seconds of effective PPV

Post-Golden Minute — Escalation

MR SOPA (Ventilation Corrective Steps)

Key Numbers

Core principle: In neonatal resuscitation, ventilation is the single most important intervention. Effective PPV within the Golden Minute is the cornerstone of preventing neonatal asphyxia-related mortality and morbidity.

Neonatal Resuscitation — Complete Overview

The Resuscitation Algorithm

BIRTH
  │
  ▼
Rapid Assessment (5 sec)
  ├─ Term? Good tone? Breathing/crying?
  │     YES to ALL → Routine Care
  │     ANY NO ↓
  ▼
GOLDEN MINUTE — Initial Steps
  Warm → Airway → Dry → Stimulate → Reposition
  │
  ▼
Assess: HR + Respirations at 60 sec
  │
  ├── HR ≥100 + breathing → Observe, O₂ if needed
  │
  └── Apnea OR HR <100 → PPV
          │
          ▼ (after 15 sec PPV)
       Assess HR
          │
     HR ≥100 → Continue PPV, wean O₂
          │
     HR 60–99 → MR SOPA corrections
          │
     HR <60 after 30 sec effective PPV
          │
          ▼
    CHEST COMPRESSIONS + PPV
          │
          ▼ (after 60 sec)
       HR still <60
          │
          ▼
      EPINEPHRINE + Consider intubation

Step-by-Step Details

1. Initial Assessment at Birth

2. Initial Steps (Golden Minute — 60 sec)

Meconium: No routine suctioning. Intubate + suction only if non-vigorous (poor tone, apnea, HR <100).

3. Positive Pressure Ventilation (PPV)

MR SOPA — Ventilation Corrective Steps

4. Chest Compressions

5. Medications

Epinephrine

Volume Expander

6. Umbilical Cord Management (2023 Update)

7. Post-Resuscitation Care

Target SpO₂ After Birth (Pre-Ductal)

Key Principles to Remember

1. Ventilation is the single most important intervention in neonatal resuscitation
2. Most newborns respond to PPV alone — compressions and drugs are rarely needed
3. 2-thumb technique is preferred for chest compressions
4. Switch to 100% O₂ when starting compressions
5. Umbilical vein is the fastest IV access in neonates
6. Always consider reversible causes: hypovolemia, pneumothorax, congenital anomalies